Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001086273 | SCV000548923 | likely benign | Adams-Oliver syndrome 5 | 2023-11-28 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV000764819 | SCV000895970 | uncertain significance | Aortic valve disease 1; Adams-Oliver syndrome 5 | 2018-10-31 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000826311 | SCV000967894 | likely benign | not provided | 2018-03-27 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
CHEO Genetics Diagnostic Laboratory, |
RCV001170168 | SCV001332718 | benign | Familial thoracic aortic aneurysm and aortic dissection | 2018-02-01 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000826311 | SCV004162053 | benign | not provided | 2022-10-01 | criteria provided, single submitter | clinical testing | NOTCH1: PP2, BS1, BS2 |
Ambry Genetics | RCV001170168 | SCV004990164 | uncertain significance | Familial thoracic aortic aneurysm and aortic dissection | 2020-04-03 | criteria provided, single submitter | clinical testing | The c.1699A>G (p.I567V) alteration is located in exon 11 (coding exon 11) of the NOTCH1 gene. This alteration results from a A to G substitution at nucleotide position 1699, causing the isoleucine (I) at amino acid position 567 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
ITMI | RCV000121657 | SCV000085855 | not provided | not specified | 2013-09-19 | no assertion provided | reference population |